Exact Sciences buys fellow oncology diagnostics company Genomic Health for $2.8B
The companies tout the deal as expanding Exact's commercial footprint to 90 countries and creating a leader in the cancer diagnostic space with projected 2020 revenues of $1.6 billion.
